Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-180315
Filing Date
2014-05-02
Accepted
2014-05-02 16:59:55
Documents
14
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d702439d10q.htm 10-Q 474132
2 EX-10.75 d702439dex1075.htm EX-10.75 277012
3 EX-31.1 d702439dex311.htm EX-31.1 8358
4 EX-31.2 d702439dex312.htm EX-31.2 8427
5 EX-32.1 d702439dex321.htm EX-32.1 3341
6 EX-32.2 d702439dex322.htm EX-32.2 3370
13 GRAPHIC g702439148.jpg GRAPHIC 5396
14 GRAPHIC g702439149.jpg GRAPHIC 2645
  Complete submission text file 0001193125-14-180315.txt   3224210

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT drrx-20140331.xml EX-101.INS 388693
8 XBRL TAXONOMY EXTENSION SCHEMA drrx-20140331.xsd EX-101.SCH 26444
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drrx-20140331_cal.xml EX-101.CAL 49129
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20140331_def.xml EX-101.DEF 87991
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20140331_lab.xml EX-101.LAB 214402
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20140331_pre.xml EX-101.PRE 166159
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 14810226
SIC: 2834 Pharmaceutical Preparations